COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Food and Drug Administration has updated and reissued its April 18 emergency use authorization on face masks for the general public to clarify that non-surgical face masks are not intended for use by health care personnel as personal protective equipment, meaning they are not a substitute for…
The Trump administration put forward a series of guidelines for testing and rapid response programs in anticipation of reopening the nation’s economy.
he Centers for Medicare & Medicaid Services April 28 and April 30 will host calls for hospitals, health systems and providers on COVID-19.
The Food and Drug Administration April 24 reminded health care providers of the need to closely monitor patients for serious and potentially life-threatening side effects of hydroxychloroquine and chloroquine when used off-label to treat COVID-19.
CMS last week updated its infection control guidance for home health agencies participating in Medicare and Medicaid and for religious non-medical health care institutions participating in Medicare.
The Centers for Medicare & Medicaid Services April 26 announced it is reevaluating the amounts that will be paid under its Accelerated Payment Program and suspending its Advance Payment Program effective immediately.
The Food and Drug Administration issued guidance allowing patients to use certain non-invasive fetal and maternal monitoring devices in the home during the COVID-19 emergency to reduce the need for in-clinic visits.
The Centers for Disease Control and Prevention has released contingency and crisis capacity strategies for the cleaning, decontamination and use of reusable elastomeric respirators during surge demand situations.
The Centers for Medicare & Medicaid Services released a toolkit for states to more quickly adopt Medicaid and Children's Health Insurance Program policies for telehealth's use during the COVID-19 pandemic.
The Centers for Disease Control and Prevention will award $631 million in Coronavirus Aid, Relief, and Economic Security Act funding to help public health agencies expand surveillance, testing and contact tracing to identify COVID-19 cases, protect vulnerable populations, and work with health care…